Sharmishtha Samantaray

Title: Sharmishtha Samantaray: Innovator in Bioconjugate Therapeutics

Introduction

Sharmishtha Samantaray is a prominent inventor based in New Delhi, India. She has made significant contributions to the field of bioconjugates, particularly in developing therapeutic agents through innovative synthesis methods. Her work is characterized by a novel enzymatic approach that has the potential to enhance target delivery of compounds.

Latest Patents

Sharmishtha holds a patent for her invention titled "Bioconjugates as therapeutic agent and synthesis thereof." This patent describes an unprecedented sortase-catalyzed transpeptidation reaction. The reaction involves a substrate comprising the LPXTG peptide motif and various biomolecules, including aminosugars and nucleic acids. The bioconjugates produced through this method are useful for targeted delivery, showcasing her innovative approach to therapeutic development. She has 1 patent to her name.

Career Highlights

Sharmishtha is currently associated with the National Institute of Immunology, where she continues her research and development in immunology and bioconjugate therapeutics. Her work has garnered attention for its potential applications in medicine and drug delivery systems.

Collaborations

Sharmishtha collaborates with Rajendra Prasad Roy, enhancing her research efforts and contributing to the advancement of bioconjugate technology.

Conclusion

Sharmishtha Samantaray is a trailblazer in the field of bioconjugates, with her innovative patent paving the way for future therapeutic advancements. Her contributions are vital to the ongoing research in targeted drug delivery systems.